DOSE RANGING FOR TRIALS THROUGH BIOMARKERS OF DRUG EFFECTSPOTTER, W. Z.The Journal of nutrition, health & aging. 2010, Vol 14, Num 4, pp 310-311, issn 1279-7707, 2 p.Article

Psychotherapeutic drugs and biogenic amines: current concepts and therapeutic implicationsPOTTER, W. Z.Drugs (Basel). 1984, Vol 28, Num 2, pp 127-143, issn 0012-6667Article

Psychotropic medications and work performancePOTTER, W. Z.Journal of occupational medicine. 1990, Vol 32, Num 4, pp 355-361, issn 0096-1736Article

Catecholamines in depression : a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMHGROSSMAN, F; POTTER, W. Z.Psychiatry research. 1999, Vol 87, Num 1, pp 21-27, issn 0165-1781Article

Proceedings/Beyond depression, new uses of antidepressants, symposium: 139th. annual meeting of the American Psychiatric Association,,Washington DC, May 11, 1986POTTER, W. Z.Psychologie médicale. 1986, Vol 18, Num 12, issn 0048-5756, 39 p., supplConference Proceedings

Biochemical classifications of diagnostic subgroups and D-type scoresPOTTER, W. Z; LMINNOLLA, M.Archives of general psychiatry. 1989, Vol 46, Num 3, pp 269-271, issn 0003-990XArticle

Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the newer versus the older drugsRUDORFER, M. V; POTTER, W. Z.Drugs (Basel). 1989, Vol 37, Num 5, pp 713-738, issn 0012-6667Article

Adrenoceptors and serotonin receptor function : Relevance to antidepressant mechanisms of actionPOTTER, W. Z.The Journal of clinical psychiatry. 1996, Vol 57, pp 3-8, issn 0160-6689, 5 p., SUP4Conference Paper

Catecholamines in depression : an updatePOTTER, W. Z; MANJI, H. K.Clinical chemistry (Baltimore, Md.). 1994, Vol 40, Num 2, pp 279-287, issn 0009-9147Conference Paper

Electroconvulsive therapy : a modern medical procedurePOTTER, W. Z; RUDORFER, M. V.The New England journal of medicine. 1993, Vol 328, Num 12, pp 882-883, issn 0028-4793Article

Antidepressants, metabolites, and apparent drug resistancePOTTER, W. Z; MANJI, H. K.Clinical neuropharmacology. 1990, Vol 13, pp S45-S53, issn 0362-5664, Supp. 1Conference Paper

Axonal transport of angiotensin-converting enzyme in the rat striatonigral pathwayAISO, M; POTTER, W. Z; SAAVEDRA, J. M et al.Brain research. 1988, Vol 447, Num 1, pp 195-199, issn 0006-8993Article

Quantitative autoradiography of β-adrenoceptors in the cardiac vagus ganglia of the ratSAITO, K; POTTER, W. Z; SAAVEDRA, J. M et al.European journal of pharmacology. 1988, Vol 153, Num 2-3, pp 289-293, issn 0014-2999Article

Combined lithium and electroconvulsive therapy: pharmacokinetic and pharmacodynamic interactionsRUDORFER, M. V; LINNOILA, M; POTTER, W. Z et al.Convulsive therapy. 1987, Vol 3, Num 1, pp 40-45, issn 0749-8055Article

Bipolar depression : Specific treatmentsPOTTER, W. Z.The Journal of clinical psychiatry. Supplement. 1998, Vol 59, Num 18, pp 30-36Conference Paper

Pharmacological issues in the treatment of bipolar disorder : focus on mood-stabilizing compoundsPOTTER, W. Z; KETTER, T. A.Canadian journal of psychiatry. 1993, Vol 38, pp S51-S56, issn 0706-7437, SUP2Article

Platelet α₂-adrenoreceptors in depression: a critical examinationGROSSMAN, F; MANJI, H. K; POTTER, W. Z et al.Journal of psychopharmacology (Oxford). 1993, Vol 7, Num 1, pp 4-18, issn 0269-8811Article

The pharmacologic treatment of depressionPOTTER, W. Z; RUDORFER, M. V; MANJI, H et al.The New England journal of medicine. 1991, Vol 325, Num 9, pp 633-642, issn 0028-4793Article

Comparative tolerability profiles of the newer versus older antidepressantsRUDORFER, M. V; MANJI, H. K; POTTER, W. Z et al.Drug safety. 1994, Vol 10, Num 1, pp 18-46, issn 0114-5916Article

Effects of renal clearance on plasma concentrations of homovanillic acid. Methodologic cautionsPOTTER, W. Z; HSIAO, J. K; GOLDMAN, S. M et al.Archives of general psychiatry. 1989, Vol 46, Num 6, pp 558-562, issn 0003-990XArticle

Five antidepressant treatments in depressed patients. Effects on urinary serotonin and 5-hydroxyindoleacetic acid outputLINNOILA, M; MILLER, T. L; BARTKO, J et al.Archives of general psychiatry. 1984, Vol 41, Num 7, pp 688-692, issn 0003-990XArticle

Chronic electroconvulsive shock increases D-1 receptor binding in rat substantia nigraFOCHTMANN, L. J; CRUCIANI, R; AISO, M et al.European journal of pharmacology. 1989, Vol 167, Num 2, pp 305-306, issn 0014-2999Article

Plasma norepinephrine level in affective disorders: relationship to melancholiaROY, A; PICKAR, D; LINNOILA, M et al.Archives of general psychiatry. 1985, Vol 42, Num 12, pp 1181-1185, issn 0003-990XArticle

Dose-dependent effects of intravenous alprazolam on neuroendocrine, biochemical, cardiovascular, and behavioral parameters in humansOSMAN, O. T; HSIAO, J. K; POTTER, W. Z et al.Psychopharmacologia. 1993, Vol 111, Num 3, pp 295-300, issn 0033-3158Article

Diagnosing diagnoses: receiver operating characteristic methods and psychiatryHSIAO, J. K; BARTKO, J. J; POTTER, W. Z et al.Archives of general psychiatry. 1989, Vol 46, Num 7, pp 664-667, issn 0003-990XArticle